ENDOMETRIOID OVARIAN CANCER
Clinical trials for ENDOMETRIOID OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIOID OVARIAN CANCER trials appear
Sign up with your email to follow new studies for ENDOMETRIOID OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough ovarian cancer: drug combo enters human testing
Disease control Recruiting nowThis early-phase study is testing whether combining two drugs, Cirtuvivint and Olaparib, is safe for people with ovarian cancer that no longer responds to platinum chemotherapy. About 50 women with specific genetic markers (BRCA/HRD) will take the pills at different schedules. Th…
Matched conditions: ENDOMETRIOID OVARIAN CANCER
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated May 26, 2026 11:20 UTC
-
New hope for hard-to-treat ovarian cancer: targeted drug enters phase 2 trial
Disease control Recruiting nowThis study tests a drug called TORL-1-23 in 230 women with advanced ovarian, fallopian tube, or peritoneal cancer that no longer responds to platinum chemotherapy and has a specific marker (claudin 6). The goal is to see if the drug can shrink tumors and how safe it is. Participa…
Matched conditions: ENDOMETRIOID OVARIAN CANCER
Phase: PHASE2 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated May 26, 2026 11:12 UTC
-
Virus therapy may Re-Sensitize ovarian cancer to chemo
Disease control Recruiting nowThis study tests whether a cancer-killing virus (Olvi-Vec) given into the abdomen can make platinum-resistant ovarian cancer respond to chemotherapy again. About 186 women whose cancer has not responded to at least three prior treatments will receive either Olvi-Vec plus chemo an…
Matched conditions: ENDOMETRIOID OVARIAN CANCER
Phase: PHASE3 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated May 18, 2026 12:07 UTC